In your organizations, could you please describe your approach to ensuring that appropriate patient monitoring takes place to support the safe use of a medication at the point of medication administration (i.e. at baseline, during admin, following admin)? This could include monitoring related to an IV drug known to have hypersensitivity reactions at the time of infusion OR could include monitoring following an oral antihypertensive.

Specific areas of interest that I am hoping you might include in your response:
- Who determines the monitoring parameters for any given medication whether IV, oral, chemo?
o What are the specific factors you would consider when determining the required monitoring?
- How is the expected monitoring communicated (e.g. prescriber order?, pre-printed order/built into CPOE when drug is selected?, nursing policy?, drug monograph of some kind?)?

Any and all feedback is appreciated!